Boston Scientific Corp (BSX)
NYSE · Healthcare · Medical Devices
Boston Scientific Corp is a Healthcare company with a market capitalization of $65.74B and a trailing P/E ratio of 18.5.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 22, 2026 | $0.80 | $0.79 | +1.3% |
| Q4 2025 | February 4, 2026 | $0.80 | $0.78 | +2.6% |
| Q3 2025 | October 22, 2025 | $0.75 | $0.71 | +5.6% |
| Q2 2025 | July 23, 2025 | $0.75 | $0.73 | +2.7% |
| Q1 2025 | April 23, 2025 | $0.75 | $0.67 | +11.9% |
| Q4 2024 | February 5, 2025 | $0.70 | $0.66 | +6.1% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Boston Scientific Corp's market cap?
As of June 29, 2026, Boston Scientific Corp (BSX) has a market capitalization of $65.74B.
What is Boston Scientific Corp's P/E ratio?
Boston Scientific Corp trades at a trailing price-to-earnings (P/E) ratio of 18.5. Its forward P/E is 13.2.
Does Boston Scientific Corp pay a dividend?
Boston Scientific Corp does not currently pay a dividend.
What sector is BSX in?
Boston Scientific Corp is in the Healthcare sector, specifically the Medical Devices industry.
What was Boston Scientific Corp's revenue?
In its latest reported fiscal year (ending December 31, 2025), Boston Scientific Corp reported revenue of $20.07B and net income of $2.89B.
Ask your own questions about BSX
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.